{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:19:04Z","timestamp":1792448344303,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.pbb.2020.172904","type":"journal-article","created":{"date-parts":[[2020,3,7]],"date-time":"2020-03-07T11:09:34Z","timestamp":1583579374000},"page":"172904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Neuronal brain injury after cerebral ischemic stroke is ameliorated after subsequent administration of (R)-ketamine, but not (S)-ketamine"],"prefix":"10.1016","volume":"191","author":[{"given":"Zhongwei","family":"Xiong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijia","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youge","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoyu","family":"Pu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuko","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamaki","family":"Ishima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jincao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2020.172904_bb0005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1161\/01.STR.24.7.976","article-title":"Major depression in stroke patients. A 3-year longitudinal study","volume":"24","author":"Astrom","year":"1993","journal-title":"Stroke"},{"key":"10.1016\/j.pbb.2020.172904_bb0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0304-3940(01)02520-4","article-title":"Nicotinamide and ketamine reduce infarct volume and DNA fragmentation in rats after brain ischemia and reperfusion","volume":"322","author":"Chang","year":"2002","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.pbb.2020.172904_bb0015","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.pbb.2019.04.008","article-title":"Comparison of antidepressant and side effects in mice after intranasal administration of (R,S)-ketamine, (R)-ketamine, and (S)-ketamine","volume":"181","author":"Chang","year":"2019","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172904_bb0020","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/j.neuint.2006.11.008","article-title":"Upregulation of dihydropyrimidinase-related protein 2, spectrin alpha II chain, heat shock cognate protein 70 pseudogene 1 and tropomodulin 2 after focal cerebral ischemia in rats\u2014a proteomics approach","volume":"50","author":"Chen","year":"2007","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.pbb.2020.172904_bb0025","article-title":"Distinctive effect of anesthetics on the effects of limb remote ischemic postconditioning following ischemic stroke","volume":"15","author":"Chen","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.pbb.2020.172904_bb0030","first-page":"678","article-title":"Taming the ketamine tiger","volume":"113","author":"Domino","year":"2010","journal-title":"1965. Anesthesiology"},{"key":"10.1016\/j.pbb.2020.172904_bb0035","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0014-2999(97)01116-3","article-title":"Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord","volume":"333","author":"Ebert","year":"1997","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pbb.2020.172904_bb0040","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s00213-019-05346-5","article-title":"MPTP-induced dopaminergic neurotoxicity in mouse brain is attenuated after subsequent intranasal administration of (R)-ketamine: a role of BDNF-TrkB signaling","volume":"237","author":"Fujita","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.pbb.2020.172904_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1124\/jpet.116.239228","article-title":"Antidepressant potential of (R)-ketamine in rodent models: comparison with (S)-ketamine","volume":"361","author":"Fukumoto","year":"2017","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2020.172904_bb0050","doi-asserted-by":"crossref","first-page":"683","DOI":"10.17219\/acem\/37214","article-title":"Comparison of the effects of dexmedetomidine vs. ketamine in cardiac ischemia\/reperfusion injury in rats \u2013 preliminary study","volume":"23","author":"Guler","year":"2014","journal-title":"Adv. Clin. Exp. Med."},{"key":"10.1016\/j.pbb.2020.172904_bb0055","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1017\/S0033291716000969","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without risk of brain toxicity","volume":"46","author":"Hashimoto","year":"2016","journal-title":"Psychol. Med."},{"key":"10.1016\/j.pbb.2020.172904_bb0060","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1080\/14728222.2016.1238899","article-title":"Ketamine\u2019s antidepressant action: beyond NMDA receptor inhibition","volume":"20","author":"Hashimoto","year":"2016","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.pbb.2020.172904_bb0065","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1111\/pcn.12902","article-title":"Rapid-acting antidepressant ketamine, its metabolites and other candidates: a historical overview and future perspective","volume":"73","author":"Hashimoto","year":"2019","journal-title":"Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2020.172904_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2019.12.003","article-title":"Impact of age on optimal dose of antidepressants","volume":"18","author":"Hashimoto","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.pbb.2020.172904_bb0075","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00406-016-0692-7","article-title":"Reduction of dopamine D2\/3 receptor binding in the striatum after a single administration of esketamine, but not R-ketamine: a PET study in conscious monkeys","volume":"267","author":"Hashimoto","year":"2017","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"key":"10.1016\/j.pbb.2020.172904_bb0080","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1161\/01.STR.31.8.1939","article-title":"Cognitive deficits after focal cerebral ischemia in mice","volume":"31","author":"Hattori","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.pbb.2020.172904_bb0085","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1213\/01.ANE.0000160585.43587.5B","article-title":"Revising a dogma: ketamine for patients with neurological injury?","volume":"101","author":"Himmelseher","year":"2005","journal-title":"Anesth. Analg."},{"key":"10.1016\/j.pbb.2020.172904_bb0090","article-title":"Intravenous arketamine for treatment-resistant depression: open-label pilot study","author":"Leal","year":"2020","journal-title":"Eur. Arch. Psych. Clin. Neurosci. in press."},{"key":"10.1016\/j.pbb.2020.172904_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/380403","article-title":"Preventive treatment with ketamine attenuates the ischaemia-reperfusion response in a chronic postischaemia pain model","volume":"2015","author":"Liman","year":"2015","journal-title":"Oxidative Med. Cell. Longev."},{"key":"10.1016\/j.pbb.2020.172904_bb0100","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.brainresbull.2016.05.016","article-title":"Ketamine abuse potential and use disorder","volume":"126","author":"Liu","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.pbb.2020.172904_bb0105","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.STR.31.7.1679","article-title":"Delayed treatment with nicotinamide (vitamin B(3)) improves neurological outcome and reduces infarct volume after transient focal cerebral ischemia in Wistar rats","volume":"31","author":"Mokudai","year":"2000","journal-title":"Stroke"},{"key":"10.1016\/j.pbb.2020.172904_bb0110","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s13054-016-1294-5","article-title":"Optimizing sedation in patients with acute brain injury","volume":"20","author":"Oddo","year":"2016","journal-title":"Crit. Care"},{"key":"10.1016\/j.pbb.2020.172904_bb0115","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/0006-8993(91)91742-J","article-title":"Effects of ketamine on outcome from temporary middle cerebral adtery occlusion in the spontaneously hypertensive rat","volume":"565","author":"Ridenour","year":"1991","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2020.172904_bb0120","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/jamapsychiatry.2017.0080","article-title":"A consensus statement on the use of ketamine in the treatment of mood disorders","volume":"74","author":"Sanacora","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.pbb.2020.172904_bb0125","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ijnp\/pyx108","article-title":"Lack of antidepressant effects of (2R,6R)-hydroxynorketamine in a rat learned helplessness model: comparison with (R)-ketamine","volume":"21","author":"Shirayama","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.172904_bb0130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2215-0366(17)30272-9","article-title":"Side-effects associated with ketamine use in depression: a systematic review","volume":"5","author":"Short","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.pbb.2020.172904_bb0135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11064-011-0582-3","article-title":"Inhibition of neuron-specific CREB dephosphorylation is involved in propofol and ketamine-induced neuroprotection against cerebral ischemic injuries of mice","volume":"37","author":"Shu","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.pbb.2020.172904_bb0140","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.biopsych.2015.10.018","article-title":"Intravenous esketamine in adult treatment-resistant depression: a double-blind, double-randomization, placebo-controlled study","volume":"80","author":"Singh","year":"2016","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172904_bb0145","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/jcbfm.1990.47","article-title":"A semiautomated method for measuring brain infarct volume","volume":"10","author":"Swanson","year":"1990","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.pbb.2020.172904_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.pbb.2018.07.003","article-title":"Expression of heat shock protein HSP-70 in the retrosplenial cortex of rat brain after administration of (R,S)-ketamine and (S)-ketamine, but not (R)-ketamine","volume":"172","author":"Tian","year":"2018","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172904_bb0155","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0924-977X(96)00042-9","article-title":"Differential psychopathology and patterns of cerebral glucose utilization produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)","volume":"7","author":"Vollenweider","year":"1997","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.172904_bb0160","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.wneu.2016.09.121","article-title":"Sedation of patients with acute aneurysmal subarachnoid hemorrhage with ketamine is safe and might influence the occurrence of cerebral infarctions associated with delayed cerebral ischemia","volume":"97","author":"Von der Brelie","year":"2017","journal-title":"World Neurosurg"},{"key":"10.1016\/j.pbb.2020.172904_bb0165","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1192\/bjp.151.2.200","article-title":"Depressed mood after stroke: a community study of its frequency","volume":"151","author":"Wade","year":"1987","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172904_bb0170","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1016\/S0140-6736(12)60738-7","article-title":"Recombinant tissue plasminogen activator for acute ischaemic stroke: an update systematic review and meta-analysis","volume":"379","author":"Wardlaw","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.pbb.2020.172904_bb0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.pbb.2020.172870","article-title":"A historical review of antidepressant effects of ketamine and its enantiomers","author":"Wei","year":"2020","journal-title":"Pharmacol. Biochem. Behav. in press."},{"key":"10.1016\/j.pbb.2020.172904_bb0180","doi-asserted-by":"crossref","first-page":"2904","DOI":"10.1161\/STROKEAHA.112.665331","article-title":"Risk factors for intracranial hemorrhage in acute ischemic stroke patients treated with recombinant tissue plasminogen activator: a systemic review and meta-analysis of 55 studies","volume":"43","author":"Whiteley","year":"2012","journal-title":"Stroke"},{"key":"10.1016\/j.pbb.2020.172904_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbr.2019.111904","article-title":"Beneficial effects of (R)-ketamine, but not its metabolite (2R,6R)-hydroxynorketamine, in the depression-like phenotype, inflammatory bone markers, and bone mineral density in a chronic social defeat stress model","volume":"368","author":"Xiong","year":"2019","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.pbb.2020.172904_bb0190","first-page":"115","article-title":"Effects of ketamine, midalolam, thiopental, and propofol on brain ischemia injury in rat cerebral cortical slices","volume":"25","author":"Xu","year":"2004","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.pbb.2020.172904_bb0195","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1001\/jamaneurol.2014.1210","article-title":"Symptomatic intracerebral hemorrhage in acute ischemic stroke after thrombolysis with intravenous recombinant tissue plasminogen activator: a review of natural history and treatment","volume":"71","author":"Yaghi","year":"2014","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.pbb.2020.172904_bb0200","doi-asserted-by":"crossref","first-page":"e632","DOI":"10.1038\/tp.2015.136","article-title":"R-ketamine: a rapid-onset and sustained antidepressant without psychotomimetic side effects","volume":"5","author":"Yang","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172904_bb0205","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psychres.2016.03.034","article-title":"Loss of parvalbumin-immunoreactivity in mouse brain regions after repeated intermittent administration of esketamine, but not R-ketamine","volume":"239","author":"Yang","year":"2016","journal-title":"Psychiatry Res."},{"key":"10.1016\/j.pbb.2020.172904_bb0210","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1038\/s41398-017-0031-4","article-title":"Possible role of the gut microbiota-brain axis in the antidepressant effects of (R)-ketamine sin a social defeat stress model","volume":"7","author":"Yang","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172904_bb0215","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.biopsych.2017.05.016","article-title":"Mechanistic target of rapamycin\u2013independent antidepressant effects of (R)-ketamine in a social defeat stress model","volume":"83","author":"Yang","year":"2018","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172904_bb2465","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41398-019-0624-1","article-title":"Molecular and cellular mechanisms underlying the antidepressant effects of ketamine enantiomers and its metabolites","volume":"9","author":"Yang","year":"2019","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pbb.2020.172904_bb0220","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/nature17998","article-title":"NMDAR inhibition-independent antidepressant actions of ketamine metabolites","volume":"533","author":"Zanos","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.pbb.2020.172904_bb0225","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1124\/pr.117.015198","article-title":"Ketamine and ketamine metabolite pharmacology: insights into therapeutic mechanisms","volume":"70","author":"Zanos","year":"2018","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.pbb.2020.172904_bb0230","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/14737175.2019.1554434","article-title":"An update on ketamine and its two enantiomers as rapid-acting antidepressants","volume":"19","author":"Zhang","year":"2019","journal-title":"Expert. Rev. Neurother."},{"key":"10.1016\/j.pbb.2020.172904_bb0235","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.pbb.2013.11.033","article-title":"R(\u2212)-ketamine shows greater potency and longer lasting antidepressant effects than S(+)-ketamine","volume":"116","author":"Zhang","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2020.172904_bb0240","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1093\/ijnp\/pyx100","article-title":"Role of inflammatory bone markers in the antidepressant actions of (R)-ketamine in a chronic social defeat stress model","volume":"21","author":"Zhang","year":"2018","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.pbb.2020.172904_bb0245","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41398-020-0733-x","article-title":"Essential role of microglial transforming growth factor-\u03b21 in antidepressant actions of (R)-ketamine and the novel antidepressant TGF-\u03b21","volume":"10","author":"Zhang","year":"2020","journal-title":"Transl. Psychiatry"}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305720300940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305720300940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T04:37:28Z","timestamp":1758775048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305720300940"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":50,"alternative-id":["S0091305720300940"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172904","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuronal brain injury after cerebral ischemic stroke is ameliorated after subsequent administration of (R)-ketamine, but not (S)-ketamine","name":"articletitle","label":"Article Title"},{"value":"Pharmacology Biochemistry and Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pbb.2020.172904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"172904"}}